US government to purchase Cangene anti-anthrax drug
The anthrax immune globulin (AIG) is to be made available for treating or preventing inhalational anthrax. The value of the deal, which comes as a modification to the
The European Commission (EC) has approved an extended use of Johnson & Johnson’s Tecvayli (teclistamab), along with daratumumab, to treat adult patients with relapsed or refractory multiple myeloma (r/r MM).
Heilongjiang Qitai Pharmaceutical Limited (HQPL specializes in pharmaceutical product distribution and is headquartered in the Heilongjiang province. American Oriental Bioengineering agreed to pay $4 million to acquire approximately